IHI – Thera4Care

Establish Europe as a global leader in Theranostics by addressing key challenges in the field.

Thera4Care aims to establish Europe as a global leader in Theranostics by addressing key challenges in the field. It will strengthen the manufacture and supply of Radiotheranostics for timely, cost-effective treatment delivery, develop cancer models for preclinical testing, and create a flexible framework for phase 1 clinical trials.

Additionally, the project will enhance the clinical use of Radiotheranostics through AI-driven Imaging, personalized dosing protocols, and a multi-modal Oncology platform to support physicians in treatment decision-making.

Led by GE HealthCare and the Università Cattolica del Sacro Cuore & Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Italy), the project brings together partners from 14 European countries and the United States. By addressing these foundational needs, Thera4Care is setting the stage for Europe to lead the global landscape in Theranostic development and application, ultimately improving outcomes and access for patients across the continent.

Supporting Cancer Care through European Research Projects Collaboration

The Oncidium foundation is proud to be actively part of two innovative projects led by Innovative Health Initiative (IHI)¹ and the European Commission and focused on advancing precision Oncology and Theranostics in Europe, Accelerate.eu and Thera4care.

In these two projects, Oncidium is focusing on emphasizing patient advocacy, leveraging its ambassador network and patient-centered vision, to ensure the dissemination of the project’s results within the patient and Oncology communities.

Through these efforts, the foundation reinforces its commitment to expanding access to innovative radiotheranostic solutions and improving cancer care globally.

¹The Innovative Health Initiative (IHI) is a public-private partnership (PPP) between the European Union and the European life science industries. IHI’s mission is to translate health research and innovation into tangible benefits for patients and society, and ensure that Europe remains at the cutting edge of interdisciplinary, sustainable, patient-centric health research (www.ihi.europa.eu).

Our Team